For instance, in their work, Silvis et al. [31] focused on the mechanisms and the involvement of NLRP3 inflammasome strictly in coronary artery disease and acute myocardial infarction with a brief mention of therapy options mentioning only clinical immunotherapy trials. This evidence concerns the gene NLRP3 and coronary artery disorder.